Sonnet Biotherapeutics Closes $15 Million Underwritten Public Offering; Legal Counsel Provided to Underwriter, Chardan Capital Markets LLC, by Lucosky Brookman LLP
Sonnet Biotherapeutics, a leading biotechnology company, closed a $15 million underwritten public offering. The offering was underwritten by…
Read More